Axillary Downstaging in ER(+)/HER(2-) Breast Cancer: OncotypeDX As a Tool to Guide Neoadjuvant Approach. Kantor O, Coopey SB. Ann Surg Oncol 2020 Nov 23. pii: 10.1245/s10434-020-09385.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kantor O, Coopey SB. Axillary Downstaging in ER(+)/HER(2-) Breast Cancer: OncotypeDX As a Tool to Guide Neoadjuvant Approach. Ann Surg Oncol 2020 Nov 23. pii: 10.1245/s10434-020-09385.
PMID: 33230751